Dr. Lily Pham
Neurology (Neurology Physician)
110 S Paca St
Baltimore, MD 21201
Who else practices at this address →
Baltimore city includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 126
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
MD license D94565
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Maryland Medical Center Baltimore, MD
Medical groups
- University of Maryland Neurology Associates PA (54 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 126
- Services billed
- 250
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 34 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 24 | 21 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 23 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 13 | 12 |
| Established patient office or other outpatient visit, 40-54 minutes | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levetiracetam Other prescribers in Baltimore, MD | 43 |
| Dexamethasone Other prescribers in Baltimore, MD | 15 |
| Ondansetron Hcl Other prescribers in Baltimore, MD | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 5 payments worth $149 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $64.41 |
|---|---|
| Tersera Therapeutics LLC | $36.09 |
| Daiichi Sankyo Inc. | $28.82 |
| Caris Mpi, Inc. | $19.92 |
| Food and Beverage | $149 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $630 in research payments for these studies, mostly to the institutions running them.
- ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Jazz Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.